|Articles|March 1, 2004
Cohesive agent performs reliably in all stages of surgery
Cataract surgeons who choose sodium hyaluronate 1.2% (StaarVisc II, STAAR Surgical) for their routine cases know they can rely on it from beginning to end to offer all the features they seek in a viscoelastic.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
2
AAO 2025: 12-month outcomes of travoprost intracameral implant (iDose TR) in conjunction with cataract surgery
3
Sight Sciences reports new data supporting long-term efficacy of OMNI Surgical System
4
Retina experts reflect on how OCT transformed patient care
5















































.png)


